国际医药卫生导报2012，Vol.18Issue(22)：3321-3323,3.DOI:10.3760/cma.j.issn.1007-1245.2012.22.037
曲美他嗪治疗不稳定型心绞痛(UAP)的临床疗效
Clinical efficacy of trimetazidine in treatment for unstable angina pectoris
郭建浩 1陈若峰 1周立尧 1李剑平1
作者信息
- 1. 528311 佛山市顺德区北滘医院心内科
- 折叠
摘要
Abstract
Objective To investigate the clinical efficacy of trimetazidine in the treatment of unstable angina pectoris(UAP).Methods 54 cases of UAP from June 2010 to June 2011 in our hospital were randomly divided into control group and the treatment group,the control group received conventional β 1-blockers,nitrates preparation slow-molecular-weight heparin,calcium antagonists,the treatment group based on the conventional treatment of the control group was given trimetazidine,the two groups were compared with patient outcomes.Results The angina treatment effects of the two groups of patients were 81.48％ and 92.59％,the ECG assessment results were 51.85％ and 74.07％ respectively,ischemic attack times,ischemic time as well as ischemic area of comparison all showed statistical significant differences(P ＜ 0.05).Conclusions On the basis of conventional treatment the plus of trimetazidine can better improve the patients' clinical symptoms of UAP,and has no serious adverse events in the course of treatment,the treatment is safe,effective and quite advanced among similar methods,worthy of clinic promotion and application.关键词
曲美他嗪/不稳定型心绞痛(UAP)/临床效果Key words
Trimetazidine/Unstable angina pectoris(UAP)/Clinical effect引用本文复制引用
郭建浩,陈若峰,周立尧,李剑平..曲美他嗪治疗不稳定型心绞痛(UAP)的临床疗效[J].国际医药卫生导报,2012,18(22):3321-3323,3.
